The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker

The tyrosine kinase mesenchymal–epithelial transition (cMET) is typically overexpressed in up to 75% of patients with ovarian cancer, and cMET overexpression has been associated with poor prognosis. The proteolytic release of the soluble cMET (sMET) ectodomain by metalloproteases, a process called e...

Descripción completa

Detalles Bibliográficos
Autores principales: Klotz, Daniel Martin, Link, Theresa, Goeckenjan, Maren, Wimberger, Pauline, Kuhlmann, Jan Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410524/
https://www.ncbi.nlm.nih.gov/pubmed/33690968
http://dx.doi.org/10.1002/1878-0261.12939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410524/
https://www.ncbi.nlm.nih.gov/pubmed/33690968
http://dx.doi.org/10.1002/1878-0261.12939

Ejemplares similares